We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.20 | 3.09% | 40.00 | 39.70 | 40.50 | 40.00 | 39.00 | 39.60 | 290,878 | 15:57:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -20.62 | 120.28M |
TIDMFUM
RNS Number : 7387F
Futura Medical PLC
22 May 2017
For immediate release 22 May 2017
Futura Medical plc
("Futura" or "the Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology today announces that an application has been made to the London Stock Exchange to extend its block listings of securities in respect of a total of 3,360,000 ordinary shares of 0.2 pence each (the "Ordinary Shares") which may arise pursuant to the exercise of options under its Unapproved Share Option Scheme ("USOS") and its EMI Share Option Scheme ("EMI").
Admission of the above additional shares to be block listed is expected to occur on or around 25 May 2017.
The Company makes the following update on its block listings, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over Ordinary Shares.
The table below provides further detail:
Name of company: Futura Medical plc Name of scheme(s): USOS EMI Period of return: From: 25 November 2016 To: 22 May 2017 USOS: 1,156,321 EMI: 1,364,141 ----------------------------------------- Number and class of securities not issued under the scheme(s) at beginning of period Total: 2,520,462 Number and class of securities admitted to the scheme(s) in the period USOS: 1,466,208 EMI: 1,893,792 ----------------------------------------- Total: 3,360,000 Number of securities issued under the scheme(s) during the period Number of securities lapsed under the scheme(s) during the period USOS: (176,419) EMI: (236,543) USOS: - EMI: - Balance of securities under the scheme(s) not yet issued at the end of the period USOS: 2,446,110 EMI: 3,021,390 ----------------------------------------- Total: 5,467,500 Number and class of securities USOS: 814,424 on 25 May 2011, 1,202,280 on 8 originally admitted and the date of October 2013, admission 1,466,208 on 25 May 2017 USOS Total: 3,482,912 EMI: 1,520,576 on 25 May 2011, 1,467,720 on 8 October 2013, 1,893,792 on 25 May 2017 EMI Total: 4,882,088 Total: 8,365,000 Name of contact: Derek Martin, Chief Financial Officer Telephone number of contact: +44 (0) 1483 685 670
For further information please contact:
Futura Medical plc James Barder, Chief Executive Tel: +44 (0) 1483 685 670 Email to: james.barder@futuramedical.com www.futuramedical.com N+1 Singer (Nominated Adviser and Broker) Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496 Corporate Finance 3000 For media enquiries please contact: Buchanan Mark Court / Sophie Cowles Tel: +44 (0) 20 7466 / Stephanie Watson 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRPGUUWAUPMGQG
(END) Dow Jones Newswires
May 22, 2017 02:01 ET (06:01 GMT)
1 Year Futura Medical Chart |
1 Month Futura Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions